As his first year as the 14th dean of the medical faculty and the second CEO of Johns Hopkins Medicine drew to a close, Dr. Rothman recently offered his perspective on the current state of Johns Hopkins Medicine and provided an update of the extraordinary initiatives that are taking place within the realms of each area of our tripartite mission: education, research and patient care.
He discussed unprecedented challenges and opportunities that the institution will face in the near future and how we aim to address them.
"People are here to innovate – to move medicine. To not be complacent with where we are. And that mission-driven society that we live here at Johns Hopkins Medicine, I think is truly remarkable and is something that is essential for us to maintain and guide us moving forward."
Stories of Innovation, Collaboration and Hope
These 10 stories provide examples of how the people of Johns Hopkins Medicine are raising the next generation of health leaders, setting the standard in innovation, and changing the field of medicine worldwide.
Complex Planning, Complex Surgery
Last December, Brendan Marrocco became the first combat veteran to receive a double arm transplant, the most extensive surgery of its kind ever performed in the United States. Watch the press conference.
To demonstrate national leadership in patient safety and quality, the Johns Hopkins Health System set and exceeded a goal of reaching 96 percent compliance on seven core measures – standardized best practices across five hospitals. With support from the Armstrong Institute for Patient Safety and Quality, this achievement clearly demonstrates our collective commitment to provide our patients with the best care.
Eliminating Boundaries of Care
The Johns Hopkins Community Health Partnership, a new health care delivery model launched last year, aims improve quality of patient care and the overall health of East Baltimore, while preventing unnecessary and costly hospital readmissions and emergency room visits.
First Functional HIV Cure in an Infant
Johns Hopkins Children\’s Center virologist Deborah Persaud, M.D., along with a team of researchers from the Johns Hopkins Children’s Center, the University of Mississippi Medical Center, and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.
All Hands on Deck
The Hopkins Hands campaign aims to remind employees at all levels that hand hygiene remains a top priority and encourages every staff member to practice and improve good hand hygiene skills to protect patients, visitors, colleagues and friends. Learn more about Clean Hands at Johns Hopkins.
An Epic Achievement
After nearly two years of intense planning, training and preparation, Johns Hopkins Medicine began the migration to Epic, our new electronic medical record system, heralding an institution-wide commitment to exceptional patient care and safety.
Leading the Change: Five-Year Strategic Plan
We’re working in a rapidly changing health care environment. With the input of a multidisciplinary team of faculty and staff, Johns Hopkins Medicine developed a five-year strategic plan to lead the change. Learn more about the Five-Year Strategic Plan.
This past May, our graduating class of medical degree students was the first to have completed all four years of a new, innovative curriculum called Genes to Society. The goal of the curriculum is to teach students to think differently about health and disease and to incorporate genetic, socioeconomic and lifestyle factors when evaluating and treating patients.
Hopkins Investigator Awarded Breakthrough Prize in Life Sciences
Bert Vogelstein, M.D., co-director of the Ludwig Center at Johns Hopkins and a Howard Hughes Medical Institute investigator has been awarded the Breakthrough Prize in Life Sciences. He was selected for his landmark work in cancer genomics and tumor suppressor genes. Vogelstein is among 11 inaugural winners who will receive $3 million each for their groundbreaking research in the life sciences.